Ali H. El‐Bahrawy

597 total citations
18 papers, 466 citations indexed

About

Ali H. El‐Bahrawy is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Ali H. El‐Bahrawy has authored 18 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Pharmacology. Recurrent topics in Ali H. El‐Bahrawy's work include PARP inhibition in cancer therapy (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Chemotherapy-induced organ toxicity mitigation (3 papers). Ali H. El‐Bahrawy is often cited by papers focused on PARP inhibition in cancer therapy (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Chemotherapy-induced organ toxicity mitigation (3 papers). Ali H. El‐Bahrawy collaborates with scholars based in Egypt, United States and Saudi Arabia. Ali H. El‐Bahrawy's co-authors include Ramadan A.M. Hemeida, Farid M.A. Hamada, Hossam M.M. Arafa, Fares E.M. Ali, A. Hamid Boulares, Mohamed A. Ghonim, Amarjit S. Naura, Emad H. M. Hassanein, Youssef Errami and Hogyoung Kim and has published in prestigious journals such as Journal of Biological Chemistry, The FASEB Journal and Life Sciences.

In The Last Decade

Ali H. El‐Bahrawy

18 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali H. El‐Bahrawy Egypt 10 179 122 85 59 49 18 466
Titto Augustine United States 12 231 1.3× 147 1.2× 38 0.4× 43 0.7× 81 1.7× 19 496
Bryant Megna United States 9 152 0.8× 84 0.7× 44 0.5× 27 0.5× 64 1.3× 23 370
Guoguo Jin China 14 350 2.0× 142 1.2× 74 0.9× 68 1.2× 16 0.3× 25 643
Kalpana K. Bhanumathy Canada 13 220 1.2× 69 0.6× 64 0.8× 27 0.5× 19 0.4× 35 574
Hsi‐Hsien Hsu Taiwan 12 309 1.7× 177 1.5× 61 0.7× 79 1.3× 34 0.7× 31 646
Yasmeen M. Attia Egypt 13 173 1.0× 103 0.8× 24 0.3× 42 0.7× 27 0.6× 25 432
Vijay S. Thakur United States 11 342 1.9× 102 0.8× 40 0.5× 126 2.1× 31 0.6× 13 575
Hsiao‐Fan Chen Taiwan 14 358 2.0× 127 1.0× 48 0.6× 38 0.6× 33 0.7× 22 640
Karishma Gupta United States 9 355 2.0× 91 0.7× 41 0.5× 105 1.8× 37 0.8× 30 704
Ki‐Baik Hahm South Korea 15 172 1.0× 78 0.6× 64 0.8× 33 0.6× 40 0.8× 21 580

Countries citing papers authored by Ali H. El‐Bahrawy

Since Specialization
Citations

This map shows the geographic impact of Ali H. El‐Bahrawy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali H. El‐Bahrawy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali H. El‐Bahrawy more than expected).

Fields of papers citing papers by Ali H. El‐Bahrawy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali H. El‐Bahrawy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali H. El‐Bahrawy. The network helps show where Ali H. El‐Bahrawy may publish in the future.

Co-authorship network of co-authors of Ali H. El‐Bahrawy

This figure shows the co-authorship network connecting the top 25 collaborators of Ali H. El‐Bahrawy. A scholar is included among the top collaborators of Ali H. El‐Bahrawy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali H. El‐Bahrawy. Ali H. El‐Bahrawy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
3.
Khalaf, Ahmed, et al.. (2024). Relation between ABO and RhD and prevalence and severity of COVID-19 disease. 2(3). 78–86. 3 indexed citations
4.
Fadaly, Wael A. A., Yaseen A. M. M. Elshaier, Fares E.M. Ali, et al.. (2024). Vicinal diaryl pyrazole with tetrazole/urea scaffolds as selective angiotensin converting enzyme‐1/cyclooxygenase‐2 inhibitors: Design, synthesis, anti‐hypertensive, anti‐fibrotic, and anti‐inflammatory. Drug Development Research. 85(4). e22217–e22217. 15 indexed citations
5.
Ali, Fares E.M., et al.. (2023). Neuroprotective effect of lansoprazole against cisplatin-induced brain toxicity: Role of Nrf2/ARE and Akt/P53 signaling pathways. Journal of Chemical Neuroanatomy. 132. 102299–102299. 3 indexed citations
6.
Alatawi, Ahmed D., Marwa O. Elgendy, Ahmed M. Sayed, et al.. (2023). Local and Systemic side effects of COVID-19 Vaccines. 2(1). 11–20. 3 indexed citations
7.
Al-Wahaibi, Lamya H., Yaser A. Mostafa, Mostafa Abdelrahman, et al.. (2022). Synthesis and Biological Evaluation of Indole-2-Carboxamides with Potent Apoptotic Antiproliferative Activity as EGFR/CDK2 Dual Inhibitors. Pharmaceuticals. 15(8). 1006–1006. 29 indexed citations
8.
Ghonim, Mohamed A., Salomè V. Ibba, Youssef Errami, et al.. (2021). Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1 immunotherapy in colon cancer. Journal for ImmunoTherapy of Cancer. 9(1). e001643–e001643. 69 indexed citations
9.
Ali, Fares E.M., et al.. (2021). Targeting KEAP1/Nrf2, AKT, and PPAR-γ signals as a potential protective mechanism of diosmin against gentamicin-induced nephrotoxicity. Life Sciences. 275. 119349–119349. 33 indexed citations
10.
Ali, Fares E.M., et al.. (2021). Nephroprotective effect of umbelliferone against cisplatin‐induced kidney damage is mediated by regulation of NRF2, cytoglobin, SIRT1/FOXO‐3, and NF‐kB‐p65 signaling pathways. Journal of Biochemical and Molecular Toxicology. 35(5). e22738–e22738. 40 indexed citations
11.
12.
El‐Bahrawy, Ali H., Hogyoung Kim, Venkat Subramaniam, et al.. (2016). ApoE deficiency promotes colon inflammation and enhances the inflammatory potential of oxidized-LDL and TNF-α in primary colon epithelial cells. Bioscience Reports. 36(5). 7 indexed citations
13.
Errami, Youssef, Ali H. El‐Bahrawy, Amir A. Al-Khami, et al.. (2016). THE DUAL ACTIONS OF DNA REPAIR ENZYME, PARP‐1, IN COLON INFLAMMATION AND CARCINOGENESIS. The FASEB Journal. 30(S1). 1 indexed citations
14.
Ghonim, Mohamed A., Salomè V. Ibba, Amir A. Al-Khami, et al.. (2015). PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4+ T cell function. Journal of Translational Medicine. 13(1). 225–225. 43 indexed citations
15.
Errami, Youssef, Ali H. El‐Bahrawy, Amarjit S. Naura, et al.. (2015). PARADOXICAL ROLES OF PARP‐1 IN COLON INFLAMMATION AND TUMORIGENESIS. The FASEB Journal. 29(S1). 1 indexed citations
16.
Kim, Hogyoung, Zakaria Y. Abd Elmageed, Ali H. El‐Bahrawy, et al.. (2014). Correlation between PDZK1, Cdc37, Akt and Breast Cancer Malignancy: The Role of PDZK1 in Cell Growth through Akt Stabilization by Increasing and Interacting with Cdc37. Molecular Medicine. 20(1). 270–279. 29 indexed citations
17.
18.
Arafa, Hossam M.M., Ramadan A.M. Hemeida, Ali H. El‐Bahrawy, & Farid M.A. Hamada. (2009). Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model. Food and Chemical Toxicology. 47(6). 1311–1317. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Titto Augustine Breakdown of academic impact, for papers by Bryant Megna Breakdown of academic impact, for papers by Guoguo Jin Breakdown of academic impact, for papers by Kalpana K. Bhanumathy Breakdown of academic impact, for papers by Hsi‐Hsien Hsu Breakdown of academic impact, for papers by Yasmeen M. Attia Breakdown of academic impact, for papers by Vijay S. Thakur Breakdown of academic impact, for papers by Hsiao‐Fan Chen Breakdown of academic impact, for papers by Karishma Gupta Breakdown of academic impact, for papers by Ki‐Baik Hahm
Rankless by CCL
2026